Robert Willcocks News Today

Three senior members of the fund manager are to join its board of directors in 2023. The appointments include Trilogy Funds chief operating officer Justin Smart, head of lending and property assets

Living Cell Technologies Limited (ASX:LCT – Get Rating) insider Robert Willcocks bought 10,000,000 shares of Living Cell Technologies stock in a transaction dated Friday, June 3rd. The shares were acquired at an average cost of A$0.01 ($0.01) per share, with a total value of A$70,000.00 ($50,359.71). The company has a current ratio of 11.80, a […]